KoreaMed Synapse

Journal List > Korean J Gastroenterol > v.61(6) > 1007095

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Lee: Are Serum Immunoglobulin and Tumor Marker Helpful in Differentiating Autoimmune Pancreatitis from Pancreatobiliary Malignancies?

Editorial

Korean J Gastroenterol 2013;61(6):301-302.

Published online: 4 October 2013

DOI: https://doi.org/10.4166/kjg.2013.61.6.301

Are Serum Immunoglobulin and Tumor Marker Helpful in Differentiating Autoimmune Pancreatitis from Pancreatobiliary Malignancies?

Jong Kyun Lee

Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence to: Jong Kyun Lee, Division of Gastroenterology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea. Tel: +82-2-3410-3409, Fax: +82-2-3410-6983, E-mail: jongk.lee@samsung.com

Copyright © 2013 Korean Ophthalmological Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

A Comparative Study on Serum Immunoglobulin and Tumor Marker Levels in the Patients with Autoimmune Pancreatitis and Pancreatobiliary Malignancies

References

1. Okazaki K, Uchida K, Matsushita M, Takaoka M. Autoimmune pancreatitis. Intern Med. 2005; 44:1215–1223.

2. Kamisawa T, Egawa N, Nakajima H, et al. Comparison of radiological and histological findings in autoimmune pancreatitis. Hepatogastroenterology. 2006; 53:953–956.

3. Oh HC, Kim MH, Lee KT, et al. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010; 25:1831–1837.

4. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732–738.

5. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 14:3948–3955.

6. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of carbohydrate antigen 19–9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004; 19:182–186.

7. Yoon H, Kim MH, Won SH, et al. A comparative study on serum immunoglobulin and tumor marker levels in the patients with autoimmune pancreatitis and pancreatobiliary malignancies. Korean J Gastroenterol. 2013; 61:327–332.

8. Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associ-ated cholangitis from cholangiocarcinoma. Hepatology. 2011; 54:940–948.

9. Ohara H, Nakazawa T, Kawa S, et al. Establishment of a serum igg4 cut-off value for the differential diagnosis of igg4-related sclerosing cholangitis-A Japanese cohort. J Gastroenterol Hepatol. 2013. [Epub ahead of print].

10. Kanno A, Nishimori I, Masamune A, et al. Research Committee on Intractable Diseases of Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas. 2012; 41:835–839.

TOOLS

Similar articles